Perspectives from those who live it every day.
A new research study published June 20 in Neuropathology and Applied Neurobiology found key biological differences between aggressive and more indolent, less harmful brain tumors that develop in neurofibromatosis type 1 (NF1) patients. NF1 is a genetic disorder that can predispose those affected to benign and cancerous nervous system tumors. “These findings may lead to […]
Our next podcast with Dr Bill Nelson is now available. Today, he speaks with neurologic oncologist Dr Byram Ozer about the multi-disciplinary approach to brain cancer at Sibley Memorial Hospital in Washington DC. In this preview, Dr Ozer discusses how the potential side effects faced by patients with brain cancer are managed. To listen to […]
Pictured: Nanoparticles releasing microRNAs inside a brain cancer cell. Johns Hopkins Kimmel Cancer Center brain cancer researchers announced that they successfully delivered ultra-tiny nano-size packets of genetic code, called microRNAs, in animal models of human brain cancer. This multi-specialty study was led by John Laterra, M.D., Ph.D., co-director of the Kimmel Cancer Center Brain Cancer […]
A rare cell line developed by Johns Hopkins researchers is giving scientists their first chance in decades to test new therapies for a lethal pediatric brain cancer that has few treatments. Kimmel Cancer Center scientist Eric H. Raabe, M.D., Ph.D., helped to develop the diffuse intrinsic pontine glioma (DIPG) cell line, grown from tumor tissue donated by […]
This isn't a new story, nor one that has a definitive answer. Public health and other experts are still trying to sort out any link between cell phones and brain cancer, and now, the World Health Organization (WHO) has added radiofrequency electromagnetic fields emitted by cell phones and other devices to a list of "possible" carcinogens. Jonathan […]
